Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of IV Ibuprofen and Paracetamol for Low Back Pain
NCT02836509Phase 4
Key facts
- Status
- Unknown
- Start
- Sep 2016
- Primary completion
- Dec 2016
- Sponsor
- Pamukkale University
- Modality
- Small Molecules
- Conditions
- low back pain (LBP)
01
Overview
Phase 4, randomised, double-blind trial in low back pain (LBP) comparing Paracetamol Group with Ibuprofen Group (2 arms). Primary endpoint: Reduction of Low Back Pain on the Visual Analog Scale. Status: unknown.
02
Design
2 arms- Study design
- RandomizedDouble-blind
Paracetamol Group
1000 mg Paracetamol in 150 ml normal saline IV.
Ibuprofen Group
800 mg Ibuprofen in 150 ml normal saline IV.
03
Who it enrols
Adult patients (21-80 years) presenting to the ED with low back pain starting in the last week. Excludes patients with chronic pain, neurological symptoms, hypotension, fever, peptic ulcer, or recent analgesic use.
04
Endpoints
Primary
Reduction of Low Back Pain on the Visual Analog Scale
Secondary
Adverse events
Beyond the preview
Go deeper on NCT02836509.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02836509.